Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

5 things we learned from the RPS practice pharmacist webinar

The Royal Pharmaceutical Society hosted a webinar last week (August 12) to answer questions about a national pilot that will see pharmacists employed in GP surgeries across England

The Royal Pharmaceutical Society (RPS) and NHS England have revealed more details on a national pilot that will see up to 250 pharmacists employed in GP practices.

NHS England programme director Ian Biggs joined RPS president Ash Soni and others last week to answer questions during a webinar on the pilot, which will install one senior pharmacist and five clinical pharmacists in pilot sites across England for three years. 

Here's the pick of what we learned.

 

  1. NHS England want a “mix of proposals” for the different pilot sites

Mr Biggs told webinar attendees that NHS England wants "40 to 50" pilot sites, but the exact figure would depend on the proposals it receives from GP practices applying for the scheme

NHS England wants a "mix of proposals" that show how pharmacists will "solve a need" in the GP surgery, Mr Biggs said. The commissioning body will ensure "geographical spread" of pilot sites, he said.

 

  1. Pharmacists from “all walks of life” should apply for the proposals

Heidi Wright, English practice and policy lead at the RPS, said the practice pharmacist role was not limited to one pharmacy sector, and was open to any “pharmacists who have the correct knowledge to do that role”. RPS president Ash Soni agreed that the only important factor was a pharmacist's “ability to do the job”.

Mr Biggs said that the one senior pharmacist at each pilot site – who will supervise five clinical pharmacists – needs to be an independent prescriber.

 

  1. Practices need to consider prescriber training and costs

NHS England's £15 million funding for the scheme – which will pay 60% of the pharmacists' fees for the first year of the pilot, dropping to 20% in the final year – will only pay salary costs, Mr Biggs said

The money would not “top off the funding for prescriber training” that GPs may want pharmacists they employ to undertake, he said.

 

  1. Other pharmacy staff are excluded from the pilot

Mr Biggs revealed that NHS England "debated" allowing the wider pharmacy team, including pharmacy technicians, to participate in the pilot, but eventually decided that it should be limited to pharmacists.

 

  1. The project will be well underway at the start of 2016

Mr Biggs told the webinar that between 240 and 250 pharmacists will work in GP practices, with the exact figure depending on these pharmacists' salaries. 

"Most" of these pharmacists will be employed by January next year, he said. 

 


What other questions do you have about the practice pharmacy pilot?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD007630

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel